Pharmather Holdings Stock Investor Sentiment

PHRRF Stock  USD 0.17  0.02  10.53%   
Roughly 62% of Pharmather Holdings' investor base is looking to short. The analysis of current outlook of investing in Pharmather Holdings suggests that many traders are alarmed regarding Pharmather Holdings' prospects. The current market sentiment, together with Pharmather Holdings' historical and current headlines, can help investors time the market. In addition, many technical investors use Pharmather Holdings stock news signals to limit their universe of possible portfolio assets.
Pharmather Holdings otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharmather daily returns and investor perception about the current price of Pharmather Holdings as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
PharmaTher Closer to Resolving US Ketamine Shortage - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
PharmaThers Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cephara...
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine - ...
Google News at Macroaxis
over six months ago at news.google.com         
PharmaTher Provides Update for Expected FDA Approval of Ketamine - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Heres Why Were Not Too Worried About PharmaTher Holdings Cash Burn Situation - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Psychedelics Researchers Industry Leaders Weigh In On ... - The Dales Report
Google News at Macroaxis
over a year ago at news.google.com         
Psychedelic Drugs Market revenue to exceed USD 12 Billion by 2035, says Research Nester - Yahoo Fina...
Google News at Macroaxis
over a year ago at news.google.com         
PharmaTher Submits Priority Original Abbreviated New Drug ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Transdermal Medical Patch Market worth 10.79 Billion by 2028 - Exclusive Report by The Insight Partn...
Google News at Macroaxis
over a year ago at news.google.com         
Colorado Regulators Rollout Regulated Access Regulations For ... - The Dales Report
Google News at Macroaxis
over a year ago at news.google.com         
Psilocybin-like drug may help people suffering from anorexia COMPASS study - Mugglehead
Google News at Macroaxis
over a year ago at news.google.com         
PharmaDrug Announces Strategic Investment in Sairiyo Therapeutics Inc. - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
How Healing REIT Is Poised to Build A National Real Estate Footprint - The Dales Report
Google News at Macroaxis
over a year ago at news.google.com         
Why Cybin Could See Greater Opportunities After MAPS 2023 - The Dales Report
Google News at Macroaxis
over a year ago at news.google.com         
PharmaThers Novel Ketamine Heads For The US Market With New Collaboration Agreement - PharmaTher Hol...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharmather Holdings that are available to investors today. That information is available publicly through Pharmather media outlets and privately through word of mouth or via Pharmather internal channels. However, regardless of the origin, that massive amount of Pharmather data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharmather Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharmather Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharmather Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharmather Holdings alpha.

Pharmather Holdings Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharmather OTC Stock analysis

When running Pharmather Holdings' price analysis, check to measure Pharmather Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmather Holdings is operating at the current time. Most of Pharmather Holdings' value examination focuses on studying past and present price action to predict the probability of Pharmather Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmather Holdings' price. Additionally, you may evaluate how the addition of Pharmather Holdings to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals